These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10636116)

  • 21. YAP1-MAML2 fusion in a pediatric NF2-wildtype intraparenchymal brainstem schwannoma.
    Karajannis MA; Li BK; Souweidane MM; Liechty B; Yao J; Benhamida JK; Bale TA; Rosenblum MK
    Acta Neuropathol Commun; 2022 Aug; 10(1):117. PubMed ID: 35986430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Complex treatment of a patient with neurofibromatosis type 2].
    Rynda AY; Olyushin VE; Rostovtsev DM; Zabrodskaya YM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(8):98-104. PubMed ID: 32929931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurofibromatosis 2 in the pediatric age group.
    Mautner VF; Tatagiba M; Guthoff R; Samii M; Pulst SM
    Neurosurgery; 1993 Jul; 33(1):92-6. PubMed ID: 8355853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of Noninvasive, Quantifiable, Orthotopic Animal Models for NF2-Associated Schwannoma and Meningioma.
    Burns SS; Chang LS
    Methods Mol Biol; 2016; 1427():59-72. PubMed ID: 27259921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetics of familial and non-familial skull base tumours.
    Irving RM; Moffat DA; Maher ER
    Clin Otolaryngol Allied Sci; 1995 Feb; 20(1):5-11. PubMed ID: 7788935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiplex ligation-dependent probe amplification (MLPA) screening in meningioma.
    Martínez-Glez V; Franco-Hernández C; Lomas J; Peña-Granero C; de Campos JM; Isla A; Rey JA
    Cancer Genet Cytogenet; 2007 Mar; 173(2):170-2. PubMed ID: 17321335
    [No Abstract]   [Full Text] [Related]  

  • 27. [Meningiomas: prognostic relevance of histopathologic and genetic markers].
    Kros JM; Wolbers JG
    Ned Tijdschr Geneeskd; 2001 Nov; 145(45):2160-5. PubMed ID: 11727613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. hTERT promoter methylation in meningiomas and central nervous hemangiopericytomas.
    Fürtjes G; Köchling M; Peetz-Dienhart S; Wagner A; Heß K; Hasselblatt M; Senner V; Stummer W; Paulus W; Brokinkel B
    J Neurooncol; 2016 Oct; 130(1):79-87. PubMed ID: 27465278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibrous meningioma in a patient with von Hippel-Lindau disease: a genetic analysis.
    Governale LS; Vortmeyer AO; Zhuang Z; Oldfield EH
    J Neurosurg; 2001 Dec; 95(6):1045-9. PubMed ID: 11765821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular alterations in the neurofibromatosis type 2 gene and its protein rarely occurring in meningothelial meningiomas.
    Evans JJ; Jeun SS; Lee JH; Harwalkar JA; Shoshan Y; Cowell JK; Golubic M
    J Neurosurg; 2001 Jan; 94(1):111-7. PubMed ID: 11147878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SMARCB1 mutations are not a common cause of multiple meningiomas.
    Hadfield KD; Smith MJ; Trump D; Newman WG; Evans DG
    J Med Genet; 2010 Aug; 47(8):567-8. PubMed ID: 20472658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple cranial nerve schwannomas and meningiomas as a hallmark sign of neurofibromatosis type 2 in a child.
    Halefoğlu AM
    Turk J Pediatr; 2018; 60(1):107-110. PubMed ID: 30102490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role and regulatory mechanism of IL-1β on the methylation of the NF2 gene in benign meningiomas and leptomeninges.
    Wang B; Cui Z; Zhong Z; Sun Y; Yang GY; Sun Q; Bian L
    Mol Carcinog; 2016 Dec; 55(12):2268-2277. PubMed ID: 26840621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current standing and frontiers of gene therapy for meningiomas.
    De La Garza-Ramos R; Flores-Rodríguez JV; Martínez-Gutiérrez JC; Ruiz-Valls A; Caro-Osorio E
    Neurosurg Focus; 2013 Dec; 35(6):E4. PubMed ID: 24289129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical detection of schwannomin and neurofibromin in vestibular schwannomas, ependymomas and meningiomas.
    Huynh DP; Mautner V; Baser ME; Stavrou D; Pulst SM
    J Neuropathol Exp Neurol; 1997 Apr; 56(4):382-90. PubMed ID: 9100669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low frequency of replication errors in primary nervous system tumours.
    Sobrido MJ; Pereira CR; Barros F; Forteza J; Carracedo A; Lema M
    J Neurol Neurosurg Psychiatry; 2000 Sep; 69(3):369-75. PubMed ID: 10945812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Molecular genetics of familial tumour syndromes of the central nervous system].
    Murnyák B; Szepesi R; Hortobágyi T
    Orv Hetil; 2015 Feb; 156(5):171-7. PubMed ID: 25618858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Aberrant methylation of NF2, TIMP-3 and THBS1 genes and their diagnostic values in meningiomas].
    Gong J; Zhu SG; Wu CY; Li XG; Liu YG; Ren XH; Zhang Y
    Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(41):2889-92. PubMed ID: 23328233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Neurocutaneous syndromes and tumors of the central nervous system].
    Takakura K; Teramoto A
    No To Shinkei; 1984 Jan; 36(1):36-48. PubMed ID: 6428438
    [No Abstract]   [Full Text] [Related]  

  • 40. Bilateral acoustic neurinomas with multiple meningiomas.
    ROVINE BW; MULFORD EH
    Neurology; 1960 Mar; 10():323-4. PubMed ID: 14439650
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.